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Since the divergence of humans and chimpanzees about 5 million years ago, these species have undergone a
remarkable evolution with drastic divergence in anatomy and cognitive abilities. At the molecular level, despite the
small overall magnitude of DNA sequence divergence, we might expect such evolutionary changes to leave a
noticeable signature throughout the genome. We here compare 13,731 annotated genes from humans to their
chimpanzee orthologs to identify genes that show evidence of positive selection. Many of the genes that present a
signature of positive selection tend to be involved in sensory perception or immune defenses. However, the group of
genes that show the strongest evidence for positive selection also includes a surprising number of genes involved in
tumor suppression and apoptosis, and of genes involved in spermatogenesis. We hypothesize that positive selection in
some of these genes may be driven by genomic conflict due to apoptosis during spermatogenesis. Genes with maximal
expression in the brain show little or no evidence for positive selection, while genes with maximal expression in the
testis tend to be enriched with positively selected genes. Genes on the X chromosome also tend to show an elevated
tendency for positive selection. We also present polymorphism data from 20 Caucasian Americans and 19 African
Americans for the 50 annotated genes showing the strongest evidence for positive selection. The polymorphism
analysis further supports the presence of positive selection in these genes by showing an excess of high-frequency
derived nonsynonymous mutations.
Citation: Nielsen R, Bustamante C, Clark AG, Glanowski S, Sackton TB, et al. (2005) A scan for positively selected genes in the genomes of humans and chimpanzees. PLoS Biol
3(6): e170.
Introduction
Genes, or regions of the genome, that have been affected by
natural selection may show an excess of functionally
important molecular changes, beyond what would be ex-
pected in the absence of selection. Genomic regions with such
an excess of changes are said to have experienced positive
selection, i.e., selection in favor of new genetic variants. The
most common statistical technique for detecting positive
selection takes advantage of the fact that mutations in coding
regions of genes come in two classes: nonsynonymous
mutations that change the resulting amino acid sequence of
the protein and synonymous mutations, which do not change
the encoded protein. An excess of nonsynonymous mutations
over synonymous mutations, beyond what would be expected
if the two types of mutations occur at the same rate, provides
strong evidence for the past action of positive selection at the
protein level. Using this logic, there have recently been
numerous studies documenting positive selection in a variety
of genes and organisms, including immune-response-related
genes [1–3], viral genes [4–6], fertilization genes [7,8], and
genes involved in sensory perception and olfaction in humans
[9].
Clark et al. [10] compared 7,645 genes from humans to
their orthologs from the chimpanzee and the mouse. For each
gene, they tested if there was an excess of nonsynonymous
substitutions on the evolutionary lineage leading to humans.
They showed that there was an excess of putatively positively
selected genes in several functional classes, including genes
involved in sensory perception, olfaction, and amino acid
catabolism. They also showed that human genes that have
been targeted by positive selection are signiﬁcantly more
likely to harbor variation associated with known genetic
diseases. We here report the results of an analysis of 20,361
human and chimpanzee genes (of which 6,630 later were
eliminated in a very conservative quality control), which
includes the 7,645 genes analyzed by Clark et al. [10]. While
the objective of the study by Clark et al. [10] was to ﬁnd genes
that have experienced accelerated evolution on the human
lineage, using the mouse as an outgroup, the aim of the
current study is to ﬁnd genes that have been targeted by
positive selection at any point in time during the evolution of
humans and chimpanzees, based on a larger set of genes. We
use a likelihood ratio test to identify positive selection and do
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the test. Positive selection is inferred if the ratio of
nonsynonymous substitutions per nonsynonymous site to
synonymous substitutions per synonymous site (dN/dS) is
statistically signiﬁcantly greater than one in a test of the
neutral null hypothesis dN/dS = 1 [11,12]. The method used
for detecting positive selection takes transition/transversion
rate biases and unequal codon and amino acid frequencies
into account. The test for positive selection applied in this
study is a traditional test of dN/dS greater than one. It has
more power than the test used in the Clark et al. study [10] if
selection affects both the human and the chimpanzee lineages
because it uses information from both lineages.
Results
Chimpanzee sequence was obtained by PCR using primers
designed to ﬂank exon sequence annotated in the human
genome [10]. Our analysis begins with data from 20,361
coding regions, including 103,606 nucleotide differences and
403 indels among 17,687,331 aligned nucleotides. These
numbers are signiﬁcantly lower than the genome-wide
averages [13,14], presumably due to selective constraints in
the coding regions. The distributions of nonsynonymous and
synonymous nucleotide differences among genes are shown
in Figure 1. The average numbers of nonsynonymous and
synonymous mutations per nucleotide site are 0.002578 and
0.003281, respectively. Eliminating reads without a hit to
known genes in public databases (see Materials and Methods),
there are 71,896 nucleotide differences in 13,731 genes. The
remaining analysis is restricted to this set of genes. Among
them, 5,574 were eliminated from the positive selection
analysis because they had fewer than three mutations, and
797 were eliminated because the sequence was less than 50 bp
long. Additionally, 45 genes were eliminated because they
contained internal stop codons, presumably due to erroneous
annotations or sequencing errors. Among the remaining
8,079 genes, 3,913 were also analyzed by Clark et al. [10].
The average level of sequence divergence was 0.60%,
corresponding to a divergence level of 1.57% in silent sites.
This ﬁgure matches well the level of divergence observed by
Ebersberger et al. [14] for Chromosome 22 of 1.44% overall
and 2.26% in CpG islands.
Seven hundred thirty-three of the 8,079 genes evolved with
dN/dS greater than one, but only 35 had p-values less than 0.05,
as determined by a likelihood ratio test of the null hypothesis
of dN/dS = 1 against the alternative hypothesis of dN/dS greater
than one. The number of signiﬁcant genes at the 5% level, in
this one-sided test, is lower than the nominal level because
the vast majority of genes are conserved and evolve with dN/dS
less than one. Nonetheless, after using Simes’s improved
Bonferroni procedure [15] we can, at the 5% signiﬁcance
level, reject the hypothesis that none of the genes are evolving
with dN/dS greater than one. This also implies that a 5% false
discovery rate set is nonempty. Even though the level of
divergence between humans and chimpanzees is very low,
there is statistically signiﬁcant evidence for positive selection
in the DNA sequences of these two species. Results for all
genes are available in Dataset S1.
Biological Processes Affected by Positive Selection
To identify functional groups of genes with an over-
representation of putatively positively selected genes, we used
the PANTHER [16,17] classiﬁcation of biological processes
and a Mann-Whitney U test (MWU) based on the p-values
from the likelihood ratio test (Table 1). The classiﬁcation
based on the MWU identiﬁes categories of genes with small p-
values from the likelihood ratio test. It is important to notice
that genes that evolve approximately neutrally will tend to
have smaller p-values than genes evolving under strong
functional constraints. The classiﬁcation based on the MWUs,
therefore, does not provide unambiguous evidence for
positive selection, but it provides a key to which groups
harbors the most candidates for positive selection.
Immune-defense-related genes appear at the top of the list.
It is not surprising that several of the genes experiencing
most positive selection are involved in immune responses to
viruses. Considering the speed at which many pathogens, such
as viruses, evolve (e.g., [5]), a coevolutionary molecular arms
race between pathogens and host cells might explain the
presence of strong selection favoring new mutations in these
genes. Other forces, including overdominant selection to
diversify the spectrum of immune responses, may also cause
positive selection in immune- and defense-related genes.
Such explanations have previously been used to explain the
presence of positive selection in the human major histo-
compatibility complex [18].
As in [10] we also identify genes involved in various forms
of sensory perception, including olfaction and genes classi-
ﬁed as ‘‘unknown biological function.’’ Many of the genes
with unknown biological function show sequence similarity
with known transcription factors (data not shown). Much of
the selection on sensory genes is driven by the selection on
olfactory receptors previously found by Gilad et al. [9].
IncontrasttoClarketal.[10],wealsoﬁndthatgenesinvolved
in spermatogenesis appear to have an excess of positively
selectedgenes.Thegenesinvolvedinspermatogenesisshowing
the strongest evidence for positive selection include several
KRAB-containing zinc ﬁnger proteins that serve as repressors
oftranscriptionandarebelievedtobeinvolvedindetermining
the differentiation of pluripotent stem cells [19].
Expression Patterns and Positive Selection
We also categorized 3,464 of the 8,079 genes according to
the tissue of expression in the Novartis Gene Expression Atlas
Figure 1. Distribution of Mutations
The ﬁgure shows the number of synonymous and nonsynonymous
nucleotide differences in 13,731 human–chimpanzee orthologous
gene pairs.
DOI: 10.1371/journal.pbio.0030170.g001
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Positive Selection in Humans and Chimpanzees[20]. Because of the relatively small number of tissue-selective
genes in our dataset (204) and the large number of tissues
analyzed (28), many tissues had fewer than 20 tissue-selective
genes, providing little statistical power for further subdivi-
sion. Therefore, we examined instead whether the tissue of
maximal expression for a gene was correlated with positive
selection, since high expression levels and importance in
tissue function are often, but not always, correlated. The set
of genes that have their maximal expression in the testes is
the only one showing an excess of positive selection, after a
Bonferroni correction for multiple tests (Table 2).
Genes with their maximal expression in the brain do not
have an excess tendency toward positive selection. In fact,
genes expressed in the brain seem to be among the most
conserved genes with the least evidence for positive selection.
MWUs, comparing genes with their maximal expression in
the brain (83 genes) to all other genes, show that these genes
tend to have signiﬁcantly higher p-values of the likelihood
ratio test for positive selection (p = 0.035), indicating high
levels of selective constraint. Genes that are expressed in the
brain at a level of twice the expression level found in blood
show an even stronger tendency toward avoidance of positive
selection (p = 0.0002). Although studies of gene expression in
the brain tissue are complicated by low-abundance tran-
scripts and heterogeneous specialized brain regions [21], the
overall evidence points toward a deﬁciency of positively, or
fast evolving, genes among those expressed in the brain. The
causes for the cognitive differences may instead be sought in
adaptive changes in just a few genes, in changes in gene
expression [22], or in changes in copy number and/or
organization of genes relating to cognitive function [23].
Dorus et al. [24] found that genes expressed in the nervous
system showed a relative increase in the rate in primates
relative to rodents when compared to housekeeping genes,
but provided no direct evidence for positive selection on
these genes. Nervous-system-speciﬁc genes appear to be so
conserved that it is unlikely that direct evidence for positive
selection will be discovered in this group of genes.
Positive Selection in the X Chromosome
We also tested if any chromosomes show an excess of genes
with evidence for positive selection. The only chromosome
enriched in genes with small p-values from the likelihood
ratio test for positive selection is the X chromosome (p =
0.0049; MWU). Several factors inﬂuence the contrast between
the X and autosomes in tests of selection, including hemi-
zygosity of the X in males, resulting in more effective
selection against deleterious recessive and in favor of positive
recessive mutations [25]. Male hemizygosity also results in
mutations, with male-speciﬁc effects being more readily ﬁxed
by selection on the X [26]. This increased efﬁciency of
selection for male-speciﬁc genes on the X may explain the
excess of X-linked genes expressed in spermatogonia [27].
The observation that reproductive proteins generally evolve
at a greater rate, coupled with the overrepresentation of
male-speciﬁc genes on the X, could produce the excess
positive selection seen on the X. However, after eliminating
all genes with highest expression levels in the testis, or
annotated as functioning in spermatogenesis, there is still an
excess of putatively positively selected genes on the X
chromosome (p = 0.0131; MWU). Thus, it appears that the
elevated positive selection on the X is likely due to the
general tendency of mutations to be recessive, regardless of
their tendency to be male-limited in expression. Although
other factors, such as an elevated male mutation rate [28],
differences in the efﬁcacy of genetic hitchhiking between
autosomes and the X chromosome [29], and correlations
Table 1. Biological Process Categories with an Excess of
Putatively Positively Selected Genes (Nominal p less than 0.05;
MWU) among a Total of 133 Biological Process Categories
Biological Process Number of Genes p-Value
Immunity and defense 417 0.0000
T-cell-mediated immunity 82 0.0000
Chemosensory perception 45 0.0000
Biological process unclassified 3,069 0.0000
Olfaction 28 0.0004
Gametogenesis 51 0.0005
Natural killer-cell-mediated immunity 30 0.0018
Spermatogenesis and motility 20 0.0037
Inhibition of apoptosis 40 0.0047
Interferon-mediated immunity 23 0.0080
Sensory perception 133 0.0160
B-cell- and antibody-mediated immunity 57 0.0298
Note that the categories overlap; e.g., ‘‘T-cell-mediated immunity’’ is entirely nested within ‘‘Immunity and
defense.’’
DOI: 10.1371/journal.pbio.0030170.t001
Table 2. Test for an Excess of Putatively Positively Selected
Genes by Tissue Type
Tissue of Maximal Expression Number of Genes p-Value
Testis 247 0.0002
Thyroid 66 0.0287
Thymus 82 0.0599
Prostate 76 0.0902
Fetal_liver 114 0.1668
Salivary_gland 195 0.1696
Whole_blood 405 0.239
Heart 120 0.2906
Lung 64 0.3381
Trachea 47 0.3976
Liver 244 0.4468
Uterus 51 0.493
Adrenal_gland 70 0.5434
Spleen 134 0.5582
Pancreas 358 0.6063
Pituitary_gland 60 0.6493
Placenta 179 0.7566
Cortex 36 0.7696
Kidney 179 0.801
Amygdala 43 0.8398
Corpus_callosum 101 0.8909
Caudate_nucleus 36 0.8945
Thalamus 33 0.9018
Fetal_brain 201 0.912
Ovary 133 0.9295
Whole_brain 83 0.965
Cerebellum 93 0.9903
Spinal_cord 14 1
Small p-values (MWU; nominal p-values not corrected for multiple testing) indicate an excess of putatively positively
selected genes in the tissue type.
DOI: 10.1371/journal.pbio.0030170.t002
PLoS Biology | www.plosbiology.org June 2005 | Volume 3 | Issue 6 | e170 0978
Positive Selection in Humans and Chimpanzeesbetween recombination rate and divergence [30], may cause
differences in variability and substitution rate between
autosomes and the X chromosome, none of these factors
alone can explain the excess of positively selected genes on
the X chromosome.
Analysis of the 50 Genes Showing Strongest Evidence for
Selection
We studied the 50 genes with the highest likelihood ratios
in greater detail to further characterize the causes of positive
selection and examine error rates (Table 3). To investigate the
degree to which our results might be inﬂuenced by sequenc-
ing errors, we compared the data for these genes with the
public data available for the same genes. In the regions with
overlap between the public data and our data there were a
total of 327 mutations in the public data and 306 mutations
in our data. This demonstrates that there is not an excess of
(potentially artifactual) mutations in our data in the genes
that show evidence for positive selection. While most of the
50 genes also show strong evidence for positive selection in
the public data, six of the genes do not. HC19953, HC2758,
HC6579, HC7761, HC8067, and HC9844 do not have dN/dS
ratios larger than one in the public data. In most cases, the
difference is caused by the fact that our database and the
public database contain different regions of the genes. Not all
regions of a gene are expected to be targeted by positive
selection, but this does not challenge the evidence for positive
selection in the regions of the genes included in this analysis.
In any case, using the public data would not change the
qualitative conclusions of the analysis of the genes presented
here.
Immunity and Defense Genes Targeted by Positive
Selection
The top 50 genes include many genes that we might a priori
expect to be targets of positive selection, including four genes
involved in olfaction (OR2W1, OR5I1, OR2B2, and C20orf185)
and several genes involved in host–pathogen interactions,
such as CMRF35H, CD72 antigen, pre-T-cell antigen receptor
a (PTCRA), APOBEC3F, and granzyme H (GZMH). Only one of
these genes was among the 50 most signiﬁcant entries in the
Clark et al. [10] model 2 analysis. APOBEC3F encodes an
antiviral factor that has previously been demonstrated to be
under positive selection by Sawyer et al. [3] who note that this
gene has been associated with anti-HIV activity.
Presumably, most of these genes have been targeted by
positive selection throughout the primate and mammalian
phylogeny. The widespread evidence for positive selection in
immune-related genes conﬁrms the hypothesis that much
positive selection in the human and mammalian genomes
may be driven by a coevolutionary arms race between host
immune system and pathogens.
Spermatogenesis- and Apoptosis-Related Genes
The list also contains many testis- or sperm-speciﬁc genes
including Protamine-1 (PRM1), which previously has been
shown to be under positive selection [31], possibly due to
sperm competition (but see [32] for an alternative explan-
ation). Other sperm-speciﬁc genes on the list include USP26,
C15orf2, PEPP-2, TCP11, HYAL3, and TSARG1. The inclusion
of these genes in the list of the genes showing the strongest
evidence for positive selection is consistent with the results,
b a s e do nt h eP A N T H E Ra n n o t a t i o na n dt h eN o v a r t i s
expression data, of excess positive selection in sperm/testis-
speciﬁc genes. The possible causes include sperm competition
(e.g., [31]), sexual conﬂict (e.g., [7,8]), selection for reproduc-
tive isolation, pathogen-driven selection in the reproductive
organs, and selection related to the occurrence of mutations
causing segregation distortion.
We notice that at least one of these genes (TSARG1) is
involved in apoptosis during spermatogenesis. Apoptosis of
germ cells is conspicuous during normal spermatogenesis,
eliminating up to 75% of the potential spermazoa [33–35],
affecting cells both before and after the meiotic division [36].
It has been hypothesized that the main cause for the high rate
of apoptosis during spermatogenesis is to maintain a proper
cell-number ratio between maturing germ cells and Sertoli
cells [35]. The natural process of elimination of germ cells by
apoptosis creates a genomic conﬂict in which each individual
germ cell will beneﬁt from avoiding apoptosis, but apoptosis
of a certain fraction of germ cells may be beneﬁcial to the
mature organism. New mutations occurring in cells during
spermatogenesis, which reduces the probability of apoptosis,
will be positively selected. This effect will be particularly
strong for mutations in genes expressed after the meiotic
division, potentially resulting in segregation distortion. A
mutant with an even very small increase in the probability of
escaping postmeiotic apoptosis will have a strong selective
advantage. Compensatory mutations, reducing or eliminating
the effect of the apoptosis avoidance mutation, may then
later occur. These dynamics may lead to recurrent events of
positive selection in genes affecting spermatogenesis apop-
tosis. The 40 genes in this study involved in inhibition of
apoptosis show an excess of evidence for positive selection
compared to other categories (p = 0.0047; see Table 2). Many
of the genes showing most evidence for positive selection are
known to be involved in either spermatogenesis, apoptosis, or
both. For example, the apoptosis-related gene showing the
strongest evidence for positive selection (DFFA) is an
inhibitor of Fas-mediated apoptosis, which has been shown
to be involved in apoptosis during spermatogenesis [36]. This
may suggest that genomic conﬂict due to spermatogenesis
apoptosis may be driving positive selection in many of the
included genes.
Cancer-Related Genes
While we expected to ﬁnd genes involved in olfaction,
spermatogenesis, and immune defense among the 50 anno-
tated genes showing the strongest evidence for positive
selection, we were surprised to ﬁnd a very large proportion
of cancer-related genes, especially genes involved in tumor
suppression, apoptosis, and cell cycle control. These genes
include four putative tumor suppressors: HYAL3, DFFA,
PEPP-2 (note that both HYAL3 and PEPP-2 also appear to
be involved in spermatogenesis), and C16orf3, another gene
associated with tumor progression (MMP26), and a gene with
unknown function but high similarity to melanoma-associ-
ated antigens (FLJ32965). In addition, there are several genes
involved in apoptosis (PPP1R15A, HSJ001348, TSARG1, and
GZMH). Given that many of the genes have very little
functional information, it is surprising to ﬁnd such a large
proportion of genes that may be related to tumor develop-
ment and control. The factors causing positive selection on
these genes are unknown, but genes important in tumor
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to other functional effects of the genes, particularly in
immunity and defense or in spermatogenesis. Several of the
genes involved in tumor suppression or progression show
testis-speciﬁc expression, and models of genomic conﬂict may
explain the presence of positive selection in these genes. It
should be noted that there is no pattern of human-speciﬁc
selection in these genes. The high number of nonsynonymous
mutations in these genes is approximately evenly distributed
between the human and the chimpanzee lineage (results not
shown).
PAML Analysis
For each of the 50 genes, we searched public databases to
ﬁnd orthologous genes in other mammals. For 25 of the genes
we were able to identify orthologs from mouse and rat, and
for these 25 genes we estimated the dN/dS ratio of each lineage
Table 3. The Top 50 Genes Showing Evidence for Positive Selection
HC Name
a Gene Name Function NDHC
b SD HC
c NP H
d SP H
e HC LR
f
HC208 PRM1 Substitutes for histones in sperm 9 0 0 2 10.12208
HC15768 CMRF35H Leukocyte membrane antigen 13 0 0 0 9.262642
HC12140 DGAT2L1 Fatty acid synthesis (presumed) 10 1 2 0 6.625498
HC1860 FLJ46156 Unknown 10 1 4 3 6.401844
HC2436 USP26 Testis-specific expression 11 0 1 0 6.217652
HC3085 C15orf2 Testis-specific expression 18 2 12 4 6.093642
HC13803 ABHD1 Unknown 6 0 4 1 5.778402
HC11239 SCML1 Transcriptional repressor, embryonic development (presumed) 15 1 0 0 5.748762
HC3472 OR2W1 Olfactory receptor 8 0 2 1 5.702798
HC10799 LOC389458 Unknown 8 0 1 0 5.493604
HC7761 APOBEC3F Antiretroviral factor 11 0 2 1 5.476024
HC19072 MS4A12 Unknown 8 0 1 1 5.36116
HC4477 HYAL3 Testis-specific expression, putative tumor suppressor 5 0 2 2 5.266036
HC7681 FLJ32965 Similar to melanoma-associated antigens (function unknown) 7 0 2 0 5.24997
HC8130 LOC151534 Function unknown 7 0 0 1 5.13903
HC3434 MMP26 Zinc-binding endopeptidase, tumor progression (presumed) 7 0 2 1 4.869976
HC7508 KIAA0495 Component of the cell membrane (by similarity) 6 0 1 1 4.67452
HC4613 CD72 Signaling in the immune system 5 0 2 0 4.516886
HC14419 DFFA Inhibition of apoptosis, putative tumor suppressor 6 0 1 0 4.448548
HC11263 KRN1 Hair keratin 2 0 2 0 4.4187
HC8067 TNKS1BP1 Tankyrase-binding, multifunctional (presumed) 6 0 2 3 4.323594
HC19953 RNPC4 RNA-binding, pre-mRNA-splicing process (presumed) 6 0 3 3 4.283004
HC1586 KRTAP19–1 Keratin-associated protein 19–1 4 0 1 0 3.923226
HC18280 HSJ001348 Apoptosis, p53-induced 10 0 0 0 3.904888
HC3104 HSA404617 Unknown 5 0 0 1 3.748416
HC15059 FLJ20489 Unknown 5 0 0 2 3.653678
HC13738 RPP38 Component of RNase P 4 0 5 2 3.638472
HC2758 FLJ35725 Unknown 4 0 3 0 3.637784
HC4426 PEPP-2 Testis-homeobox gene, putative tumor suppressor 11 0 3 1 3.602598
HC18485 PGR Progesterone receptor 11 0 2 3 3.51589
HC738 MGC57858 Unknown 3 0 2 0 3.208712
HC973 GZMH Cell lysis 12 1 1 0 3.131548
HC4889 TCP11 Germ-cell development (presumed) 3 0 2 1 3.122404
HC17263 C20orf185 Possible carrier molecule for odorants 4 1 2 3 3.047252
HC18160 PPP1R15A Growth arrest, DNA-damage inducible, apoptosis 9 2 5 5 3.007004
HC14000 SLC22A4 Cation transporter, susceptibility to rheumatoid arthritis 4 0 2 3 2.979532
HC16621 GREAT (LGR8) Receptor for relaxin. Mutations may cause cryptorchidism 4 0 1 0 2.951438
HC11003 LR8 Unknown (expressed by a lung fibroblast subpopulation) 3 0 7 0 2.948436
HC16489 HHLA1 Unknown 3 0 0 0 2.569134
HC3738 C16orf3 Putative tumor suppressor 2 0 1 1 2.56533
HC2610 CYSLTR2 Anaphylactic reactions 9 1 5 0 2.47886
HC9844 ASB11 Cytokine signaling 3 0 2 0 2.448126
HC8169 FLJ32743 Unknown 3 0 2 2 2.39831
HC12857 GDF3 Putative regulator of cell growth and differentiation 2 0 1 1 2.261462
HC6579 FLJ32844 Unknown 2 0 3 0 2.2473
HC2300 OR2B2 Olfactory receptor 3 0 3 0 2.246402
HC1723 MGC41945 Unknown 12 2 5 0 2.184832
HC3892 OR5I1 Olfactory receptor 5 1 7 4 2.152316
HC4879 PTCRA Pre-T-cell antigen receptor a 8 1 2 0 2.075898
HC16795 TSARG1 Spermatogenesis cell apoptosis 6 1 3 2 1.671884
aReference number used in Dataset S1.
bNumber of nonsynonymous differences between humans and chimps.
cNumber of synonymous differences between humans and chimps.
dNumber of nonsynonymous polymorphism in humans.
eNumber of synonymous polymorphism in humans.
fLikelihood ratio from the likelihood ratio test of dN/dS equals one versus dN/dS is greater than one in the human–chimp alignment.
DOI: 10.1371/journal.pbio.0030170.t003
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was elevated (p , 0.05) in 5/25 cases in just the human lineage,
in 5/25 cases in just the chimp lineage, in 8/25 cases in both
lineages, and in 7/25 cases signiﬁcant in neither lineage. These
results show that the elevated dN/dS ratios are a consequence
of positive selection in both the human and the chimpanzee
lineage.
Population Genetic Analysis
To further investigate the effect of selection on the 50
genes showing the strongest evidence for positive selection,
20 European-American and 19 African-American individuals
were sequenced for these genes. Forty-six of the genes
contained intraspeciﬁc polymorphism, and there were a total
of 55 synonymous polymorphisms and 116 nonsynonymous
polymorphisms, showing that the dN/dS ratio is also relatively
high in the polymorphism data.
The distribution of allele frequencies within these genes, as
summarized by the allele frequency spectrum, provides
additional support for positive selection. The frequency
spectrum (Figure 2) of synonymous polymorphisms does
not deviate from the pattern expected under a standard
neutral model [38]. However, this does not necessarily
provide evidence for the adequacy of the standard neutral
model, but may rather be caused by a cancellation of effects
due to population growth, population subdivision, and
linkage to selected mutations, low power due to the small
sample size, or by an ascertainment bias described below.
Other data in humans have shown an excess of rare derived
alleles in synonymous sites, presumably caused by population
growth [39,40]. In contrast, we ﬁnd that nonsynonymous
single nucleotide polymorphisms (SNPs) show evidence for an
excess of high-frequency-derived alleles in these genes (Figure
2). The excess of high-frequency-derived nonsynonymous
mutation supports the notion that these genes have been
targeted by positive selection. An important caveat is that an
ascertainment bias has been introduced because interspeciﬁc
and intraspeciﬁc variability has been confounded when
selecting genes with high dN/dS ratios. To assess the impact
of this ascertainment bias, we simulated 1,000 new neutral
datasets, each dataset consisting of 13,731 genes with a similar
distribution of dN/dS ratios, mutation rates, and sequence
lengths, as observed in the real data, and with both
interspeciﬁc and intraspeciﬁc variation. From these datasets
we selected the 50 genes with the largest dN/dS ratios, as in the
selection procedure applied to the real data. There is a clear
effect of the ascertainment bias on synonymous sites, but
there is essentially no effect on nonsynonymous sites (Figure
2). The main effect of the ascertainment bias is to eliminate
genes with many high-frequency-derived synonymous muta-
tions. This shows that the excess of high-frequency-derived
nonsynonymous mutations is not a result of the ascertain-
ment bias.
In addition to selection, certain demographic factors, such
as population bottlenecks and population subdivision [41,42],
and/or incorrectly inferred ancestral states may also enrich
the sample with apparent high-frequency-derived mutations.
Przeworski [42] has previously reported an excess of high-
frequency-derived mutations in human data. To investigate
this possibility we compared the frequency spectrum in our
data to the frequency spectrum of the genes in the Seattle
SNP database (SeattleSNPs; http://pga.gs.washington.edu [01/
10/03]). These data also consist of a mixture of declared
African Americans and European Americans and should,
therefore, comprise a suitable sample for comparison. With
24 out of 116 and 37 out of 360 nonsynonymous mutations of
frequency greater than 50% in our data and the Seattle data,
respectively, there is a signiﬁcant excess of high-frequency-
derived mutations in our data compared to the Seattle data (p
, 0.01, chi-square test). The Seattle data shows a slight
deﬁciency of nonsynonymous-derived mutations with fre-
quency greater than 50%, primarily due to an excess of very
low-frequency-derived mutations. These results strongly
suggest that the pattern we observe is caused by ongoing
positive selection and not by demographic effects. There are
a total of 25/78 and 22/92 polymorphisms of frequency
greater than 50% within the Caucasian and African-Ameri-
can groups, respectively. Analyzing each population sepa-
rately gives an even more extreme excess of high-frequency-
derived polymorphism, especially in the Caucasian popula-
tion.
There is a very high variance in the ratio of divergence to
polymorphism in these genes (Hudson-Kreitman-Aguade ´ test;
p less than 0.05). While the overall ratio of divergence to
polymorphism is around two (2.06), a few genes stand out as
having particularly high levels of polymorphism. For exam-
ple, one of the olfactory receptors, OR5I1, has six substitu-
tions and 11 polymorphisms. This raises the possibility that
positive selection in the olfactory receptors may be a type of
balancing selection. One possibility is heterozygote advantage
driven by selection to increase the repertoire of olfactory
receptors.
Another gene with a low divergence to polymorphism ratio
is RPP38 (four substitutions and seven polymorphisms),
which is a subunit of RNase P. RPP38 is necessary for normal
Figure 2. Frequency Spectra
The ﬁgure shows the frequency spectra of nonsynonymous (red) and
synonymous (black) mutations among the 50 genes showing the
strongest evidence for positive selection in the interspeciﬁc compar-
ison. Also shown is the expectation from the standard neutral model,
expectations from the neutral model taking the protocol used to
select the 50 genes into account (see text), and from the prediction of
the selection model. On the x-axis is the number of derived allele in a
sample of size 30 chromosomes (Count), and on the y-axis is the
proportion of sites expected in the sample with a particular
frequency.
DOI: 10.1371/journal.pbio.0030170.g002
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for antisera from systemic sclerosis patients. It is likely that
the positive selection in this gene is caused by selection to
avoid an autoimmune response. Such a hypothesis is plausible
if the sequence pattern of RPP38 inﬂuences the likelihood of
developing systemic sclerosis. This hypothesis can be tested
using linkage or linkage disequilibrium studies.
Other genes show an apparent deﬁciency of polymor-
phisms. SCML1 has 16 substitutions (of which 15 are
nonsynonymous) and zero polymorphisms. Such a pattern is
consistent with repeated selective sweeps driving divergence
between species, while eliminating variation within species.
SCML1 is a repressor of expression of Hox genes and may play
an important role in the control of embryonal development
[43]. This gene may be a prime candidate for explaining
developmental differences between humans and chimpan-
zees.
Poisson Random Field (PRF) Analysis
To further investigate the distribution of selection coef-
ﬁcients among mutations in these genes, we applied a PRF
model [44]. In PRF models, the distribution of sample allele
frequencies can be expressed as a function of the scaled
selection coefﬁcient, S, (S =2 Ns; N = population size, s =
selection coefﬁcient) acting on a mutation. We assumed that
there were three types of mutations: negatively selected
mutations (of frequency p ), neutral mutations (of frequency
p0), and positively selected mutations (of frequency pþ =1 
p  p0). We then estimated p , p0, pþ, and the scaled selection
coefﬁcients of the mutations in the two selected categories (S 
and Sþ) using maximum likelihood.
The maximum likelihood estimates of the parameters of
the PRF model are p  = 0.748, p0 = 0.172, pþ = 0.080, S  =
 34.96, and Sþ = 267.11; i.e., the estimated proportion of
negatively selected mutations is approximately 75%, and the
proportion of positively selected mutations is approximately
8%. The proportion of positively selected mutations is so
high because we have analyzed the 50 genes showing the
strongest evidence for positive selection among a very large
pool of candidate genes. Likelihood ratio tests show that a
model with three selected classes ﬁts the nonsynonymous data
signiﬁcantly better than a model with fewer selective classes
(see Materials and Methods). We conclude that the allelic
distribution in nonsynonymous sites is best described by a
mixture of neutral, positively selected and negatively selected
mutations. In this case, our best estimate of the proportion of
mutations in these genes that are neutral is less than 18%.
The predicted frequency spectrum under the estimated
selection model is shown in Figure 2.
The results of this analysis should be interpreted with some
caution because the effects of linkage have been ignored. The
effects of linkage would be to underestimate the selection
coefﬁcient and, possibly, to overestimate the number of
mutations that have been targeted by selection [45]. As
previously discussed, these types of inferences are also
sensitive to the demographic assumptions of a panmictic
population of constant size [41,42] and to the assumptions
regarding unambiguous inference of the ancestral state from
the chimpanzee. For these reasons, the exact values of the
parameter estimates should not be overinterpreted, but may
help suggest the magnitude of the selective forces necessary
to explain the data in isolation.
Discussion
The statistical methods used for detecting selection have
been the subject of debate over the past few years [46,47]. This
debate has mainly focused on the validity of methods that
model variation in the dN/dS ratio among sites. The current
test does not model rate variation among sites and should,
therefore, be uncontroversial. Unfortunately, this test may
also have very low power.
To determine the power of the test, we conducted power
simulations under parameter values estimated from the data
(Figure 3). Notice ﬁrst that the test does not result in excess
signiﬁcant results when dN/dS = 1, and results in very few
falsely signiﬁcant results when dN/dS is less than one. In fact,
when dN/dS = 1 the power is lower than the nominal
signiﬁcance level because of the possibility of ties. However,
the power increases steadily when dN/dS increases above one,
and for a gene of length 500 codons, the test has more than
80% power when dN/dS = 5. For a functional gene, in which
most sites are expected to be under functional constraints
and evolve with dN/dS less than one, a signiﬁcant value of the
test is almost surely caused by positive selection. The fact that
our data shows signiﬁcant evidence for positive selection,
when using this test with a correction for multiple tests,
illustrates that positive selection can be detected from
human–chimpanzee comparative data despite the very low
levels of divergence.
In the previous study by Clark et al. [10], an outgroup
(mouse) was used to make inferences regarding human-
speciﬁc processes. We have here analyzed a larger dataset but
cannot, in general, distinguish between selection that is
particular to the human evolutionary lineage and positive
selection that tends to occur in both chimps and humans.
While Clark et al. [10] found strongest evidence for positive
selection in genes related to olfaction and sensory percep-
tion, we ﬁnd the strongest evidence for positive selection in
genes related to immunity and defense. The reason is
probably that genes related to immunity and defense are
targets for positive selection throughout the mammalian
phylogeny, which the test used by Clark et al. [10] would not
detect, whereas much of the selection on sensory perception
and olfaction is likely to be speciﬁc to the distinct niches of
humans and chimpanzees. Similar arguments may also
explain why we obtain strong evidence for positive selection
on genes related to spermatogenesis and inhibition of
apoptosis, while Clark et al. [10] did not ﬁnd any evidence
for human-speciﬁc selection on genes related to spermato-
genesis and apoptosis.
In this paper we analyzed population genetic data from the
50 genes showing most evidence for positive selection. An
excess of high-frequency-derived nonsynonymous mutations
in these data supports the conclusions that these genes are
targeted by positive selection. Although some demographic
models also may cause an excess of high-frequency-derived
mutations [41,42], the excess observed in our data is beyond
the level observed in other comparable human data.
The use of the population genetic data may also help
suggest the mode of positive selection acting on the gene. For
example, a developmental gene (SCML1) had 16 ﬁxed
substitutions and zero polymorphisms, suggesting repeated
selective ﬁxations, whereas and olfactory receptor had six
substitutions and 11 polymorphisms consistent with the
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rative and population genetic data may help, not only to
identify positive selection, but also to help narrow down
possible models of positive selection. With the increased
availability of both comparative genomic data and SNP data,
we expect to see many future studies that take advantage of
the availability of both types of data.
The discovery that many genes involved in spermato-
genesis, apoptosis, and tumor suppression are positively
selected may prompt further investigations into models of
genomic conﬂict and other models predicting positive
selection in these genes. In general, mutations that increase
the expected number of functional sperm cells produced by a
speciﬁc germ-line cell, such as mutations increasing the rate
of cell division or decreasing the probability of apoptosis, will
be favored. Such mutations will not necessarily increase the
ﬁtness of the mature organism, leading to a genomic conﬂict,
in which selﬁsh mutations causing avoidance of apoptosis are
being counteracted by compensatory mutations in other loci.
Many of the genes with evidence for positive selection
encountered in this study play functional roles in cell cycle
regulation, tumor suppression, apoptosis, or spermatogene-
sis. We suggest that a genomic conﬂict relating to the process
of spermatogenesis may be responsible for much of the
positive selection observed in this study. Because many of
these genes are involved in inhibition of apoptosis, this may
also explain the apparent excess of cancer-related genes
targeted by positive selection. This raises the interesting
prospect that the high prevalence of cancer in humans and
other organisms may be related to selection for apoptosis
avoidance in the germ line. Mutations that in general increase
apoptosis avoidance will be selected in the germ line, but such
mutations may at the same time increase the probability of
cancer in somatic tissue. The relative high prevalence of
cancer will, according to this hypothesis, be related to an
evolutionary conﬂict between the selﬁsh interests of a germ
cell and selection at the level of mature organisms to decrease
the cancer rate. We note that the fact that the same pathways
(e.g., Fas-mediated apoptosis) are involved in the control of
cancer and in apoptosis during spermatogenesis supports this
hypothesis.
At present we cannot exclude an alternative hypothesis,
such as pathogen-driven positive selection or sperm com-
petition. Future functional and evolutionary studies of the
genes suggested to be under positive selection by this study
may help determine which of these alternative evolutionary
models are most plausible.
Materials and Methods
DNA sequencing and alignment. Sequences of chimpanzee genes
were obtained by PCR ampliﬁcation of individual exons from a single
western chimpanzee male. PCR products were directly sequenced on
automated sequencers at Celera Genomics. Details of primer
construction, DNA sequencing, and alignment were described in
Clark et al. [10] and references therein. Chimpanzee sequences were
obtained for both strands from PCR products, ﬁltered to remove base
calls with Phred scores less than 30. Genes that did not have a hit in
the curated accessions (NM_ or NR_ series) in the REFSEQ 3.0
database (http://www.ncbi.nlm.nih.gov/RefSeq/) and for which the best
hit did not map to the same genomic location in NCBI 34 build of the
human genome, were omitted from the functional analysis, to
minimize the chance of including nonfunctional genes/regions. This
was done using BLAT v. 27 (http://www.genomeblat.com/genomeblat/
index.asp). Regions of the alignment that were not in the REFSEQ
database were eliminated from the analysis. However, we provide the
full dataset (Dataset S2) for future exploration. Indels were identiﬁed
after alignment as all nonterminal gaps that could not be attributed
to low base-calling scores. All pairwise alignments are available in
Phylip and FASTA format in Dataset S2.
Human polymorphisms were detected automatically from as-
sembled sequencing traces using PolyPhred 4.0 [48] and RuleGen, a
decision-tree-based method (S. Glanowski, unpublished data). Manual
calls were employed if a potential SNP was not ﬂagged by both
programs. Validation of the automated pipeline using a set of several
hundred manually called SNPs showed a sensitivity of 85% for all
SNPs and up to 100% for SNPs with more than three minor alleles
observed. Independent veriﬁcation of several hundred SNPs using
TaqMan assays indicated that validation rates of 95% for common
SNPs and 90% for SNPs with only one minor allele were observed.
Likelihood ratio tests. For each human–chimpanzee orthologous
gene pair, a likelihood ratio test of the hypothesis of an equal dN/dS
ratio was performed using a codon-based likelihood model (see [12]
for such tests). The test was performed as a one-sided test of the
hypothesis H0: dN/dS = 1 versus the alternative of HA: dN/dS greater
than one. To reduce the computational burden, the transition/
transversion rate ratio was ﬁrst estimated for genes in high-GC-
content regions and low-GC-content regions separately. This
parameter was then considered ﬁxed for the remainder of the
analysis. Because many of the sequence pairs showed very little
divergence, the usual asymptotic assumptions of a chi-square
distribution of the likelihood-ratio test statistic would not have been
appropriate. Instead, simulations were performed to determine the
appropriate distribution of the test statistic. The simulations were
performed under the empirical distribution of the divergence time
and other parameter estimates assuming dN/dS = 1. The distribution
of the test statistic, conditional on the observed number of nucleotide
differences between the sequences (for each gene), was then
determined. One of the advantages of using the conditional
distribution is that the distribution becomes more robust to
violations of the assumptions regarding the nuisance parameters,
particularly the divergence times, and this will allow us to exclude
genes with very little variability while maintaining the right size of the
test. Genes with fewer than three nucleotide differences, or with
fewer than 50 aligned codons, were excluded from the analysis.
Functional analysis. The functional annotation was performed as
in [10], using the PANTHER database [16,17]. Throughout, excesses of
positively selected genes in a category were tested, using an MWU
comparing the distribution of p-values obtained from the likelihood
ratio tests in genes included in the category to the distribution of
such values in genes not included in the category. Genes with fewer
than three nucleotide differences between humans and chimpanzees
were excluded from the identiﬁcation of categories with an excess of
putatively positively selected genes. The MWU does not in itself
Figure 3. Power of the Likelihood Ratio Test for Positive Selection
The power is shown as a function of the proportion of the dN/dS ratio,
and for sequence lengths (n) of 150 and 500 codons. Power is deﬁned
as the proportion of tests that are signiﬁcant at the 5% level.
Simulation parameters, including codon frequencies, transition/
transversion bias, and divergence times, are equal to the values
estimated from the data. Notice the logarithmic x-axis.
DOI: 10.1371/journal.pbio.0030170.g003
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affected by positive selection, but it shows that the category contains
more evidence for positive selection than other genes in the study.
Because genes of short sequence length are less likely to show strong
evidence for positive selection, but are more likely to show spurious
evidence for positive selection, the MWU (or any other categoriza-
tion) may be affected by different sequence lengths in different
categories. The reason for using an MWU, instead of reporting
overall p-values for a category after correction for multiple testing, is
that such an approach would be strongly inﬂuenced by just one or a
few genes. However, correction for multiple testing reveals signiﬁcant
positive selection in several categories, including the immune and
defense and the spermatogenesis category.
Expression data. Expression data from normal human tissues were
obtained from the Novartis Gene Expression Atlas ([20]; http://
wombat.gnf.org/index.html); 6,741 gene symbols could be matched
unambiguously to the human–chimp alignments. All negative
expression and values less than 20 were coded as 20. Tissue selectivity
was determined by averaging probe expression values across samples
and replicate tissues. In total, 61 samples were collapsed into 28
tissues. A probe was classiﬁed as tissue selective if it was expressed in
only one tissue at a value of 200 or higher, and all other tissues were
less than 100. Probes were then collapsed into genes. A gene was
classiﬁed as tissue selective if at least one of its probes showed
speciﬁcity. The tissue of maximal expression was determined by
identifying the probe and sample (n = 61) with the highest expression
value that was greater than 20 (85% of the genes had values greater
than 200). Probes were then collapsed into genes. Tissue expression
was determined by averaging the sample replicates (n = 28). A gene
was considered expressed in a tissue if its expression value was
greater than 200.
PAML analysis. To obtain orthologous sequences for the 50
annotated genes with the highest likelihood ratios, we downloaded
‘‘Unique Best Reciprocal Hits’’ between human and mouse and
human and rat from the Ensembl Web site (http://www.ensembl.org/).
Sets of human, mouse, rat, and chimpanzee sequences were translated
and aligned using ClustalW [49]. Codon alignments were generated
using the ClustalW alignments as a guide, then manually checked.
Partial sequences covering less than 80% of the human sequence
were eliminated, and ambiguously aligned regions were masked
before analysis. The underlying phylogeny was assumed to be
([chimpanzee, human], [mouse, rat]) for all genes.
The lineage-speciﬁc analysis was done in PAML [37] by allowing
two values of the dN/dS ratio along the lineages of the phylogeny, one
for the human lineage and one for all other lineages. To test if the dN/
dS ratio was different on the human lineage, we then compared the
maximum likelihood value in this model to the maximum likelihood
value obtained, assuming the dN/dS ratio was constant among lineages.
If two times the log likelihood ratio was larger than 3.84, we rejected
the model of constant dN/dS ratio at the 5% signiﬁcance level. This
analysis was then repeated using the chimpanzee lineage as the focal
lineage instead of the human lineage.
Calculating the frequency spectrum. Because of missing data for
many polymorphisms, the frequency spectrum in a sample of size 30
is reported. The frequency spectrum was calculated in a sample of
size 30 as
pi;30 ¼ k 1 X k
j¼1
ð
fj
i
Þð
nj   fj
30   i
Þ
ð
nj
30
Þ
ð1Þ
where pi, 30 is the frequency of SNPs with derived alleles that exist in i
copies in a sample of size 30, nj is the chromosomal sample size of the
jth SNP, fj is the frequency of the derived allele for the jth SNP, k is the
number of SNPs, and ð
i
jÞ=0i fi is less than j. The polarity of the
mutationwasdeterminedusingthechimpanzeesequenceasoutgroup.
Analysis of ascertainment bias. To assess the impact of the
ascertainment scheme in the tests that contrast human polymor-
phism data to the human–chimp divergence, new datasets were
simulated, using standard neutral coalescence simulations (e.g., [38]).
Each simulated dataset generated one chimp sequence and 78 human
sequences for each of the 13,731 genes. For each simulated gene, one
human sequence was randomly chosen and compared to the chimp
sequence using a chi-square statistic for the goodness-of-ﬁt test of dN/
dS = 1. The 50 genes with largest chi-square statistic among genes
with dN/dS greater than one were selected for population genetic
analysis. This scheme was repeated 1,000 times to investigate the
effect of the ascertainment protocol of the 50 genes. The parameters
of the simulations were estimated from the data, using the observed
distribution of sequence lengths, and synonymous-site mutation rate
and humans–chimp divergence time estimated from the concaten-
ated data. The distribution of dN/dS ratios among genes was estimated
assuming the dN/dS ratios follow a c distribution among genes,
keeping the synonymous rate constant among them.
Power analysis. To analyze the power of the test for positive
selection, we simulated pairs of sequences and performed likelihood
ratio tests of H0: dN/dS equals one versus dN/dS is greater than one for
each sequence pair. The simulations were done using the average
value of synonymous sequence divergence observed in the data, while
nonsynonymous divergence was varied. For more details regarding
such simulations, see, e.g. [50].
PRF analysis. Assume nonlethal mutations enter a population of
constant size 2N according to a Poisson process and are assigned to
one of three categories: neutral (S = 0), positively selected with
selection coefﬁcient Sþ, and negatively selected with selection
coefﬁcient S , according to probabilities p0, pþ, and p  (where p0 þ
pþþp = 1). Furthermore, assume mutations evolve independently. It
follows from standard population genetic theory, the total law of
probability, and the rules of conditional probability that the
probability of an SNP being found at frequency i out of n
chromosomes under this scheme [44] is
PðX ¼ ijn;pþ;p ;p0;Sþ;S Þ
¼
pþFði;n;SþÞþp Fði;n;S Þþp0
1
i
X n 1
j¼1
pþFðj;n;SþÞþp Fðj;n;S Þþp0
1
j
ð2Þ
where Fði;n;SÞ is given by
Fði;n;SÞ¼
Z 1
0
ð
n
i
Þxið1   xÞ
n i 1   e 2Sð1 xÞ
1   e 2S
1
xð1   xÞ
dx ð3Þ
The likelihood of observing counts x1, x2,... ,xS where S is the total
number of segregating sites out of n1, n2, ..., nS chromosomes is, thus,
Lðpþ;p ;p0;Sþ;S j x;nÞ¼ P
S
j¼1
Pðxj ¼ ijnj;pþ;p ;p0;Sþ;S Þð 4Þ
The maximum likelihood value and the maximum likelihood
parameter estimates can then be obtained by numerically maximizing
this function with respect to the parameters. Likelihood ratio tests
can be constructed by constraining certain of the parameters to take
on particular values. For example, setting p0 = 1 deﬁnes a model with
no selected mutations. Likewise, setting p0 þ p  = 1 deﬁnes a model
that allows negative selection, but no positive selection.
This analysis assumes that mutations are independent. Because of
linkage and the possibility of epistasis, the independence assumption
may not be met by the data. However, a full analysis taking the
correlation among SNPs into account is not computationally feasible.
Fortunately, the average correlation is low between SNPs because
they have been sampled among 50 genes distributed throughout the
genome. The effect of the correlation among SNPs on this analysis
should, therefore, be minimal.
The maximum log likelihood value for the full model is  234.19.
However, the maximum log likelihood values for models assuming
only neutral mutations, or a single class of selected mutations, are
 243.82 and  240.88, respectively. Under the independence assump-
tion, both of these simpler models can be rejected against the model
with three classes of mutations, using a likelihood ratio test (p =
0.0006 and p = 0.004).
Supporting Information
Dataset S1. Results File
Found at DOI: 10.1371/journal.pbio.0030170.sd001 (3.1 MB XLS).
Dataset S2. Alignment File
Found at DOI: 10.1371/journal.pbio.0030170.sd002 (9.8 MB ZIP).
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Note Added in Proof
The version of this paper that was ﬁrst made available on 3 May 2005 has
been replaced by this, the deﬁnitive, version.
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